47+
Approved Products
Marketed medicines across 6 therapeutic areas
38
Countries
Global commercial and regulatory presence
10
Pipeline Assets
Active R&D programmes from discovery to registration
2,400+
Employees
Dedicated professionals worldwide
Built for Scientific Excellence
We combine the agility of a specialist biotech with the scale and infrastructure of a global pharmaceutical company.
Scientific Innovation
Our discovery engines leverage cutting-edge structural biology, AI-driven drug design, and translational science to identify and prosecute first- and best-in-class therapeutic targets.
Regulatory Excellence
With dedicated teams in 12 regulatory markets and a track record of 47+ approved products, we navigate complex global regulatory landscapes efficiently and compliantly.
Global Reach
Our commercial operations span 38 countries with a particular strength in the MENA region, ensuring patients from Dubai to Johannesburg access our medicines.
Patient Focus
Every programme we pursue is selected for its potential to address a genuine unmet medical need. Patient outcomes — not sales projections — drive our pipeline decisions.
Featured Products
A selection of our approved medicines demonstrating the breadth and depth of the UAB portfolio.
Drug Development Pipeline
Our pipeline spans 6 therapeutic areas with assets from early discovery to commercial stage.
News & Insights
Stay informed about UAB's clinical milestones, regulatory approvals, and strategic partnerships.
Partner With Us to Transform Patient Lives
We are actively seeking partners in licensing, co-development, and distribution. Connect with our Business Development team to explore collaboration opportunities.